Supernus Pharmaceuticals | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
Abbott USD 45M 6M 2024-12
ANI Pharmaceuticals USD 2.33M 2.33M 2024-09
Aurora Cannabis CAD 1.29M 768K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Canopy Growth CAD 16.77M 4.51M 2024-12
Corcept Therapeutics 6M 6M 2024-06
Eisai 777M 167M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
Indivior 9M 1000K 2024-09
Novo Nordisk 562M 40M 2024-09
Pacira USD 4.68M 9K 2024-12
Perrigo 43.1M 200K 2024-12
Pfizer USD 739M 45M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
United Therapeutics USD 7.9M 2.2M 2024-12
Xeris Pharmaceuticals USD 7.7M 83K 2024-12



Supernus Pharmaceuticals Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.